These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 16711198
1. [Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment]. Steinbeck G. MMW Fortschr Med; 2006 Apr 13; 148(15):31. PubMed ID: 16711198 [No Abstract] [Full Text] [Related]
2. [What anticoagulant therapy should be used for what form of atrial fibrillation?]. Frantz E. Dtsch Med Wochenschr; 2000 Apr 20; 125 Suppl 1():S10-1. PubMed ID: 10818997 [No Abstract] [Full Text] [Related]
3. [Atrial fibrillation (the questions of etiology, classification, and treatment)]. Gurevich MA. Klin Med (Mosk); 2006 Apr 20; 84(2):7-15. PubMed ID: 16612998 [Abstract] [Full Text] [Related]
4. Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Apostolakis S, Shantsila E, Lip GY, Lane DA. Thromb Haemost; 2009 Nov 20; 102(5):914-5. PubMed ID: 19888529 [No Abstract] [Full Text] [Related]
6. Prevention of stroke in patients with atrial fibrillation. Med Lett Drugs Ther; 2009 Jun 01; 51(1313):41. PubMed ID: 19478692 [No Abstract] [Full Text] [Related]
7. [Recommendations for peri-procedural thrombocyte aggregation inhibition]. Sauer H, Leschke M. Dtsch Med Wochenschr; 2006 Feb 24; 131(8):400-2. PubMed ID: 16479474 [No Abstract] [Full Text] [Related]
10. [The clinical challenge of the atrial fibrillation]. de Berrazueta Fernández JR. An R Acad Nac Med (Madr); 2007 Feb 24; 124(2):361-78. PubMed ID: 18069601 [Abstract] [Full Text] [Related]
11. Evidence-based emergency medicine. Anticoagulation or antiplatelet therapy for non-rheumatic atrial fibrillation and flutter. Diner BM. Ann Emerg Med; 2003 Jan 24; 41(1):141-3. PubMed ID: 12514695 [No Abstract] [Full Text] [Related]
12. [2010 AIAC Guidelines for the management and treatment of atrial fibrillation]. Raviele A, Disertori M, Alboni P, Bertaglia E, Botto G, Brignole M, Cappato R, Capucci A, Del Greco M, De Ponti R, Di Biase M, Di Pasquale G, Gulizia M, Lombardi F, Themistoclakis S, Tritto M, Italian Association of Arrhythmology and Cardiac Pacing (AIAC). G Ital Cardiol (Rome); 2011 Jan 24; 12(1 Suppl 1):7-69. PubMed ID: 22624161 [No Abstract] [Full Text] [Related]
13. [Old patient with atrial fibrillation: do you too hesitate to use anticoagulants?]. MMW Fortschr Med; 2006 Sep 21; 148(38):14. PubMed ID: 17036954 [No Abstract] [Full Text] [Related]
14. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients]. MMW Fortschr Med; 2006 Jun 08; 148(23):58-9. PubMed ID: 16826742 [No Abstract] [Full Text] [Related]
15. Antithrombotic treatment in atrial fibrillation. Lip GY, Boos CJ. Postgrad Med J; 2008 May 08; 84(991):252-8. PubMed ID: 18508982 [Abstract] [Full Text] [Related]
16. [When ASS, when anticoagulants?]. MMW Fortschr Med; 2006 Aug 17; 148(33-34):55. PubMed ID: 16981391 [No Abstract] [Full Text] [Related]
17. Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Connolly SJ, Pogue J, Eikelboom J, Flaker G, Commerford P, Franzosi MG, Healey JS, Yusuf S, ACTIVE W Investigators. Circulation; 2008 Nov 11; 118(20):2029-37. PubMed ID: 18955670 [Abstract] [Full Text] [Related]
18. Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice. Lip GY. Thromb Haemost; 2010 Apr 11; 103(4):683-5. PubMed ID: 20135056 [No Abstract] [Full Text] [Related]
19. [ASS plus clopidogrel in contraindication for marcumar]. Einecke D. MMW Fortschr Med; 2009 Apr 16; 151(16):10-1. PubMed ID: 19658286 [No Abstract] [Full Text] [Related]
20. Does current oral antiplatelet agent or subtherapeutic anticoagulation use have an effect on tissue-plasminogen-activator-mediated recanalization rate in patients with acute ischemic stroke? Ibrahim MM, Sebastian J, Hussain M, Al-Hussain F, Uchino K, Molina C, Khan K, Demchuk AM, Alexandrov AV, Saqqur M, CLOTBUST Investigators. Cerebrovasc Dis; 2010 Apr 16; 30(5):508-13. PubMed ID: 20861622 [Abstract] [Full Text] [Related] Page: [Next] [New Search]